PubMed:12488800
Annnotations
c_corpus
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-3 | CHEBI:340824 | denotes | MMP |
T4 | 0-3 | CHEBI:59761 | denotes | MMP |
T5 | 0-5 | PR:P50282 | denotes | MMP-9 |
T6 | 0-5 | PR:P14780 | denotes | MMP-9 |
T7 | 0-5 | P14780 | denotes | MMP-9 |
T8 | 0-5 | PR:P41245 | denotes | MMP-9 |
T9 | 0-5 | P41246 | denotes | MMP-9 |
T10 | 0-5 | P41245 | denotes | MMP-9 |
T11 | 0-5 | PR:P52176 | denotes | MMP-9 |
T12 | 0-5 | P50282 | denotes | MMP-9 |
T14 | 0-5 | PR:000010491 | denotes | MMP-9 |
T15 | 0-5 | P52176 | denotes | MMP-9 |
T16 | 0-5 | O18733 | denotes | MMP-9 |
T13 | 0-5 | GO:0004229 | denotes | MMP-9 |
T19 | 37-47 | 7895 | denotes | papaverine |
T17 | 37-47 | D010208 | denotes | papaverine |
T18 | 37-47 | CHEBI:28241 | denotes | papaverine |
T20 | 37-47 | D010208 | denotes | papaverine |
T21 | 57-64 | UBERON:0004111 | denotes | opening |
T22 | 72-91 | UBERON:0000120 | denotes | blood-brain barrier |
T25 | 135-139 | CHEBI:23888 | denotes | drug |
T26 | 179-186 | UBERON:0004111 | denotes | opening |
T27 | 194-213 | UBERON:0000120 | denotes | blood-brain barrier |
T30 | 215-218 | UBERON:0000120 | denotes | BBB |
T31 | 254-270 | CL:0000115 | denotes | endothelial cell |
T32 | 288-315 | C114781 | denotes | endothelial barrier antigen |
T33 | 288-315 | C114781 | denotes | endothelial barrier antigen |
T37 | 337-340 | UBERON:0000120 | denotes | BBB |
T38 | 357-363 | UBERON:0027368 | denotes | matrix |
T40 | 357-383 | P14780 | denotes | matrix metalloproteinase-9 |
T41 | 357-383 | P41246 | denotes | matrix metalloproteinase-9 |
T42 | 357-383 | P41245 | denotes | matrix metalloproteinase-9 |
T43 | 357-383 | P50282 | denotes | matrix metalloproteinase-9 |
T44 | 357-383 | PR:000010491 | denotes | matrix metalloproteinase-9 |
T45 | 357-383 | P52176 | denotes | matrix metalloproteinase-9 |
T46 | 357-383 | O18733 | denotes | matrix metalloproteinase-9 |
T39 | 357-383 | D020780 | denotes | matrix metalloproteinase-9 |
T47 | 385-388 | CHEBI:340824 | denotes | MMP |
T50 | 385-388 | CHEBI:59761 | denotes | MMP |
T51 | 385-390 | PR:P50282 | denotes | MMP-9 |
T52 | 385-390 | PR:P14780 | denotes | MMP-9 |
T53 | 385-390 | P14780 | denotes | MMP-9 |
T54 | 385-390 | PR:P41245 | denotes | MMP-9 |
T55 | 385-390 | P41246 | denotes | MMP-9 |
T56 | 385-390 | P41245 | denotes | MMP-9 |
T57 | 385-390 | PR:P52176 | denotes | MMP-9 |
T58 | 385-390 | P50282 | denotes | MMP-9 |
T60 | 385-390 | PR:000010491 | denotes | MMP-9 |
T61 | 385-390 | P52176 | denotes | MMP-9 |
T62 | 385-390 | O18733 | denotes | MMP-9 |
T59 | 385-390 | GO:0004229 | denotes | MMP-9 |
T64 | 396-416 | GO:0031012 | denotes | extracellular matrix |
T65 | 410-416 | UBERON:0027368 | denotes | matrix |
T66 | 417-425 | CHEBI:25367 | denotes | molecule |
T67 | 462-465 | UBERON:0000120 | denotes | BBB |
T68 | 466-473 | UBERON:0004111 | denotes | opening |
T69 | 519-526 | UBERON:0005396 | denotes | carotid |
T72 | 540-550 | 7895 | denotes | papaverine |
T70 | 540-550 | D010208 | denotes | papaverine |
T71 | 540-550 | CHEBI:28241 | denotes | papaverine |
T73 | 540-550 | D010208 | denotes | papaverine |
T74 | 554-558 | 10118 | denotes | rats |
T75 | 554-558 | 10116 | denotes | rats |
T76 | 554-558 | D051381 | denotes | rats |
T77 | 560-563 | UBERON:0000120 | denotes | BBB |
T78 | 564-571 | UBERON:0004111 | denotes | opening |
T105 | 620-624 | CVCL_8262 | denotes | 24 h |
T119 | 685-688 | CHEBI:340824 | denotes | MMP |
T122 | 685-688 | CHEBI:59761 | denotes | MMP |
T123 | 685-690 | PR:P50282 | denotes | MMP-9 |
T124 | 685-690 | PR:P14780 | denotes | MMP-9 |
T125 | 685-690 | P14780 | denotes | MMP-9 |
T126 | 685-690 | PR:P41245 | denotes | MMP-9 |
T127 | 685-690 | P41246 | denotes | MMP-9 |
T128 | 685-690 | P41245 | denotes | MMP-9 |
T129 | 685-690 | PR:P52176 | denotes | MMP-9 |
T130 | 685-690 | P50282 | denotes | MMP-9 |
T132 | 685-690 | PR:000010491 | denotes | MMP-9 |
T133 | 685-690 | P52176 | denotes | MMP-9 |
T134 | 685-690 | O18733 | denotes | MMP-9 |
T131 | 685-690 | GO:0004229 | denotes | MMP-9 |
T135 | 714-718 | CVCL_8262 | denotes | 24 h |
T136 | 738-741 | CHEBI:340824 | denotes | MMP |
T139 | 738-741 | CHEBI:59761 | denotes | MMP |
T140 | 738-743 | PR:P50282 | denotes | MMP-9 |
T141 | 738-743 | PR:P14780 | denotes | MMP-9 |
T142 | 738-743 | P14780 | denotes | MMP-9 |
T143 | 738-743 | PR:P41245 | denotes | MMP-9 |
T144 | 738-743 | P41246 | denotes | MMP-9 |
T145 | 738-743 | P41245 | denotes | MMP-9 |
T146 | 738-743 | PR:P52176 | denotes | MMP-9 |
T147 | 738-743 | P50282 | denotes | MMP-9 |
T149 | 738-743 | PR:000010491 | denotes | MMP-9 |
T150 | 738-743 | P52176 | denotes | MMP-9 |
T151 | 738-743 | O18733 | denotes | MMP-9 |
T148 | 738-743 | GO:0004229 | denotes | MMP-9 |
T152 | 774-777 | UBERON:0000120 | denotes | BBB |
T153 | 778-785 | UBERON:0004111 | denotes | opening |
T154 | 823-826 | CHEBI:340824 | denotes | MMP |
T157 | 823-826 | CHEBI:59761 | denotes | MMP |
T158 | 823-828 | PR:P50282 | denotes | MMP-9 |
T159 | 823-828 | PR:P14780 | denotes | MMP-9 |
T160 | 823-828 | P14780 | denotes | MMP-9 |
T161 | 823-828 | PR:P41245 | denotes | MMP-9 |
T162 | 823-828 | P41246 | denotes | MMP-9 |
T163 | 823-828 | P41245 | denotes | MMP-9 |
T164 | 823-828 | PR:P52176 | denotes | MMP-9 |
T165 | 823-828 | P50282 | denotes | MMP-9 |
T167 | 823-828 | PR:000010491 | denotes | MMP-9 |
T168 | 823-828 | P52176 | denotes | MMP-9 |
T169 | 823-828 | O18733 | denotes | MMP-9 |
T166 | 823-828 | GO:0004229 | denotes | MMP-9 |
T170 | 859-866 | UBERON:0004111 | denotes | opening |
T171 | 874-877 | UBERON:0000120 | denotes | BBB |
UseCases_ArguminSci_Discourse
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T1 | 0-92 | DRI_Approach | denotes | MMP-9 and EBA immunoreactivity after papaverine mediated opening of the blood-brain barrier. |
T2 | 93-220 | DRI_Background | denotes | Papaverine is a non-specific vasodilatory drug, which was found to unexpectedly cause opening of the blood-brain barrier (BBB). |
T3 | 221-474 | DRI_Approach | denotes | We studied the expression of two endothelial cell related markers, endothelial barrier antigen (EBA) as a marker of BBB intactness, and matrix metalloproteinase-9 (MMP-9), an extracellular matrix molecule, the activation of which results in BBB opening. |
T4 | 475-559 | DRI_Background | denotes | Immunoreactivity was quantified after intra-carotid injection of papaverine in rats. |
T5 | 560-922 | DRI_Outcome | denotes | BBB opening was identified at 1 h, but had been reversed by 24 h. Reduction in EBA-immunoreactivity occurred at 3 h, whereas MMP-9 was not observed until 24 h. The activation of MMP-9 thus occurred much later than BBB opening, which suggests a different role for MMP-9 when selective and reversible opening of the BBB is produced by pharmacological manipulation. |